Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies

AUTOR(ES)

Sandrin-Garcia, Paula, Richieri-Costa, Antonio, Tajara, Eloiza Helena, Carvalho-Salles, Andréa Borduchi, Fett-Conte, Agnes Cristina

FONTE

Genetics and Molecular Biology

DATA DE PUBLICAÇÃO

2007

RESUMO

The velocardiofacial syndrome (VCFS), a condition associated with 22q11.2 deletions, is characterized by a typical facies, palatal anomalies, learning disabilities, behavioral disturbances and cardiac defects. We investigated the frequency of these chromosomal deletions in 16 individuals with VCFS features who presented no cardiac anomalies, one of the main characteristics of VCFS. Fluorescent in situ hybridization (FISH) with the N25 (D22S75; 22q11.2) probe revealed deletions in ten individuals (62%). Therefore, even in the absence of cardiac anomalies testing for the 22q11.2 microdeletions in individuals showing other clinical features of this syndrome is recommended.

Documentos Relacionados

• Increased Prevalence of Immunoglobulin A Deficiency in Patients with the Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)
• Hematological abnormalities and 22q11.2 deletion syndrome
• Longitudinal Analysis of Lymphocyte Function and Numbers in the First Year of Life in Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)†
• avaliação de pacientes com o espectro clínico da síndrome da deleção 22q11.2 através de hibridização in situ por fluorescência e da técnica multiplex ligation-dependent probe amplification
• Cytogenetic analysis and detection of KAL-1 gene deletion with fluorescence in situ hybridization (FISH) in patients with Kallmann syndrome